Essential Pharma has acquired 1 company of its own, including 1 in the last 5 years.
The Company’s most targeted sectors include life science (100%).
8A Crabtree Road,
Egham,
TW20 8RN
United Kingdom,
+44 (0)1423 850700
www.essentialpharmagroup.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2024-04-02 |
Renaissance Pharma · Life Science
Altrincham, United Kingdom · www.renaissancepharma.co.uk Renaissance Pharma is a clinical-stage pharmaceutical company focused on the development of life changing therapies in paediatric rare disease, with its lead asset being Hu14.18K322A (Hu14.18) – an immunotherapy currently in Phase II clinical development for the treatment of high-risk neuroblastoma (HRNB). Renaissance Pharma was founded in 2023 and is based in Altrincham, England. |
- | Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
